<![CDATA[Chugai Pharmaceutical: News Releases]]> https://www.chugai-pharm.co.jp/english/index.html en-us Thu, 02 Jul 2026 15:30:00 +0900 <![CDATA[Roche’s Announcement Regarding divarasib (Announcement of Phase III Krascendo1 Study Results) ]]> https://www.chugai-pharm.co.jp/english/news/detail/20260702153000_1262.html Thu, 02 Jul 2026 15:30:00 +0900 https://www.chugai-pharm.co.jp/english/news/detail/20260702153000_1262.html <![CDATA[Launch of Joint Research Using Real-World Data and Generative AI (LLM) to Improve the Accuracy and Efficiency of Identifying Candidate Patients for Clinical Trials]]> https://www.chugai-pharm.co.jp/english/news/detail/20260630153000_1259.html Tue, 30 Jun 2026 15:30:00 +0900 https://www.chugai-pharm.co.jp/english/news/detail/20260630153000_1259.html <![CDATA[Roche’s Announcement Regarding Enspryng (FDA Accepts Application for Thyroid Eye Disease)]]> https://www.chugai-pharm.co.jp/english/news/detail/20260630170000_1260.html Tue, 30 Jun 2026 17:00:00 +0900 https://www.chugai-pharm.co.jp/english/news/detail/20260630170000_1260.html